<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00328822</url>
  </required_header>
  <id_info>
    <org_study_id>HE490424</org_study_id>
    <nct_id>NCT00328822</nct_id>
  </id_info>
  <brief_title>Quetiapine for Primary Insomnia Patients : A Randomized Controlled Trial</brief_title>
  <official_title>Quetiapine for Primary Insomnia Patients : A Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Khon Kaen University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Khon Kaen University</source>
  <brief_summary>
    <textblock>
      Primary insomnia patients will sleep with Quetiapine not better than without Quetiapine&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      1. Primary insomnia will be diagnosed according to DSM-IV-TR&#xD;
&#xD;
        2. After consenting, cases will be divided (double blind randomization)in to two arms 2.1&#xD;
           sleep hygiene with placebo group 2.2 sleep hygiene with Quetiapine group&#xD;
&#xD;
        3. outcome measurement: sleep diary, sleep satisfaction visual analog scale and sleep&#xD;
           satisfaction likert scale&#xD;
&#xD;
        4. statistical method: dependent T test&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2006</start_date>
  <completion_date type="Actual">August 2007</completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Total Sleep Time</measure>
    <time_frame>3 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Sleep Latency Period, Sleep satisfaction</measure>
    <time_frame>3 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">16</enrollment>
  <condition>Primary Insomnia</condition>
  <arm_group>
    <arm_group_label>A</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Quetiapine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>B</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Quetiapine</intervention_name>
    <arm_group_label>A</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>placebo</intervention_name>
    <arm_group_label>B</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Primary insomnia Patients by DSM-IV-TR criteria&#xD;
&#xD;
          -  cases enrolled: age 18-65 educated&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Currently receiving Quetiapine or other hypnotic drugs&#xD;
&#xD;
          -  Liver disease&#xD;
&#xD;
          -  Patients with heart Dz, Hypertension, thyroid disease&#xD;
&#xD;
          -  History of epilepsy or febrile convulsion&#xD;
&#xD;
          -  pregnant&#xD;
&#xD;
          -  cognitive impairments&#xD;
&#xD;
          -  History of Orthostatic Hypotension&#xD;
&#xD;
          -  Patient with other Psychiatric conditions or Drug dependence&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kanida Tassniyom, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Psychiatry, Faculty of Medicine, Khon Kaen University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Srinagarind Hospital, Khon Kaen University</name>
      <address>
        <city>Khon Kaen</city>
        <zip>40002</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <verification_date>October 2006</verification_date>
  <study_first_submitted>May 19, 2006</study_first_submitted>
  <study_first_submitted_qc>May 19, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 22, 2006</study_first_posted>
  <last_update_submitted>March 17, 2008</last_update_submitted>
  <last_update_submitted_qc>March 17, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 18, 2008</last_update_posted>
  <responsible_party>
    <name_title>Faculty of Medicine</name_title>
    <organization>Khon Kaen University</organization>
  </responsible_party>
  <keyword>Primary insomnia</keyword>
  <keyword>Quetiapine</keyword>
  <keyword>Randomized controlled trial</keyword>
  <keyword>Double blind</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sleep Initiation and Maintenance Disorders</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Quetiapine Fumarate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

